92993 - Clinical Audit: Oral anticoagulants -their role in AF management
- : Online
This clinical audit will allow you to:
•Proactively identify AF patients and engage in conversation regarding oral anticoagulant (OAC) options
•Improve your understanding of safety evidence for OACs and how they inform treatment decisions and subsequent management
•Improve understanding of the importance and relevance of OAC reversal in emergencies
Focus areas: Atrial Fibrillation, AF, NVAF, stroke prevention. stroke risk, cardiology, NOAC, anticoagulation, anticoagulants, clinical audit
Atrial Fibrillation (AF) is cited as the most common sustained cardiac arrhythmia observed in medical practice, ranging in severity, from isolated episodes to a chronic cardiac condition with reduced patient quality of life.
There is a largely under-appreciated AF (inclusive non-valvular AF) prevalence in Australia. It is estimated that 5.35% of the adult population aged = 55 years are affected by AF. This is expected to rise over the next 15 years to 6.39%, and AF is expected to continue to be more prevalent in older age groups, and in men compared with women.
To meet the growing demand for effective care of patients with non-valvular AF, it is important for general practitioners to deliver good care based on current state-of-the-art evidence.